In addition to myostatin, sarcopenia and sarcopenic obesity are associated with a dysregulation of other myokines with important cardiometabolic functions, such as IL-6, FNDC5/irisin, fibroblast growth factor 21 or brain-derived neurotrophic factor, which play a critical role in skeletal muscle mass and function as well as metabolic homeostasis [84]. Here, MSTN is linked to sarcopenia.